109 related articles for article (PubMed ID: 4036229)
21. A laboratory observation of some toxic effects of commercially available implant polyurethanes on HL-60 cancer cells.
Daka JN
Biomed Sci Instrum; 2003; 39():421-7. PubMed ID: 12724930
[TBL] [Abstract][Full Text] [Related]
22. Surface modification of polyurethane to promote long-term patency of peritoneal access devices.
Hunter SK; Gregonis DE; Coleman DL; Hanover B; Stephen RL; Jacobsen SC
Trans Am Soc Artif Intern Organs; 1983; 29():250-4. PubMed ID: 6673234
[No Abstract] [Full Text] [Related]
23. Introduction of some ophthalmic atropine ointments into the anterior chamber.
Sugar HS; Airala MA
Ann Ophthalmol; 1972 May; 4(5):367-74. PubMed ID: 5035069
[No Abstract] [Full Text] [Related]
24. In vivo resorption of a biodegradable polyurethane foam, based on 1,4-butanediisocyanate: a three-year subcutaneous implantation study.
van Minnen B; van Leeuwen MB; Kors G; Zuidema J; van Kooten TG; Bos RR
J Biomed Mater Res A; 2008 Jun; 85(4):972-82. PubMed ID: 17907243
[TBL] [Abstract][Full Text] [Related]
25. Medical applications of polymeric materials.
Bruck SD
Med Prog Technol; 1982; 9(1):1-16. PubMed ID: 6752684
[TBL] [Abstract][Full Text] [Related]
26. Biomedical application of commercial polymers and novel polyisobutylene-based thermoplastic elastomers for soft tissue replacement.
Puskas JE; Chen Y
Biomacromolecules; 2004; 5(4):1141-54. PubMed ID: 15244424
[TBL] [Abstract][Full Text] [Related]
27. Cholesterol-modified polyurethane valve cusps demonstrate blood outgrowth endothelial cell adhesion post-seeding in vitro and in vivo.
Stachelek SJ; Alferiev I; Connolly JM; Sacks M; Hebbel RP; Bianco R; Levy RJ
Ann Thorac Surg; 2006 Jan; 81(1):47-55. PubMed ID: 16368333
[TBL] [Abstract][Full Text] [Related]
28. [Tissue reaction to implanted polyurethane designed for parts of the artificial heart].
Staniszewska-Kuś J; Paluch D; Krzemień-Dabrowska A; Zywicka B; Solski L
Polim Med; 1995; 25(3-4):3-18. PubMed ID: 8610064
[TBL] [Abstract][Full Text] [Related]
29. In vitro evaluation of the calcification behavior of polyurethane biomaterials for cardiovascular applications.
Glasmacher-Seiler B; Reul H; Rau G
J Long Term Eff Med Implants; 1992; 2(2-3):113-26. PubMed ID: 10171618
[TBL] [Abstract][Full Text] [Related]
30. [Artificial trabeculum (MESH). Clinical and histological study in the rabbit].
Helies P; Legeais JM; Savoldelli M; Parel JM; Renard G
J Fr Ophtalmol; 1998 May; 21(5):351-60. PubMed ID: 9759429
[TBL] [Abstract][Full Text] [Related]
31. Biostable polyurethane elastomers.
Szycher M; Reed AM
Med Device Technol; 1992 Nov; 3(10):42-51. PubMed ID: 10171586
[TBL] [Abstract][Full Text] [Related]
32. [Studies on the blood compatibility of the polyurethane/nano-sized carbon composite].
Xu HY; Kong H; Lin CY; Li BY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):114-7. PubMed ID: 12905785
[TBL] [Abstract][Full Text] [Related]
33. A long-term in vitro biocompatibility study of a biodegradable polyurethane and its degradation products.
van Minnen B; Stegenga B; van Leeuwen MB; van Kooten TG; Bos RR
J Biomed Mater Res A; 2006 Feb; 76(2):377-85. PubMed ID: 16270347
[TBL] [Abstract][Full Text] [Related]
34. Biomedical applications of polyurethanes: implications of failure mechanisms.
Phillips RE; Smith MC; Thoma RJ
J Biomater Appl; 1988 Oct; 3(2):207-27. PubMed ID: 3060586
[TBL] [Abstract][Full Text] [Related]
35. [Polyurethane implant in subcutaneous connective tissue. Histological study in rats].
De Carvalho AC; Holland R; Milanezi LA; Okamoto T
Rev Fac Odontol Aracatuba; 1976; 5(1-2):63-7. PubMed ID: 1077591
[No Abstract] [Full Text] [Related]
36. Effect of soft segment length on properties of fluorinated polyurethanes.
Wang LF; Wei YH
Colloids Surf B Biointerfaces; 2005 Apr; 41(4):249-55. PubMed ID: 15748820
[TBL] [Abstract][Full Text] [Related]
37. Acid phosphatase activity as enzymatic assay of biomedical compatibility of polymers.
Burpee VF; Hackenberg RW; Hillegass DV; Arconti RJ; Sharp WV
J Biomed Mater Res; 1978 Sep; 12(5):767-771. PubMed ID: 701306
[No Abstract] [Full Text] [Related]
38. Comparative studies of the toxicity of standard reference materials in various cytotoxicity tests and in vivo implantation tests.
Tsuchiya T; Ikarashi Y; Hata H; Toyoda K; Takahashi M; Uchima T; Tanaka N; Sasaki T; Nakamura A
J Appl Biomater; 1993; 4(2):153-6. PubMed ID: 10171665
[TBL] [Abstract][Full Text] [Related]
39. In vivo biostability of polyether polyurethanes with fluoropolymer and polyethylene oxide surface modifying endgroups; resistance to metal ion oxidation.
Ward R; Anderson J; McVenes R; Stokes K
J Biomed Mater Res A; 2007 Jan; 80(1):34-44. PubMed ID: 16958046
[TBL] [Abstract][Full Text] [Related]
40. Osteoinductive biomaterials for medical implantation.
Toriumi DM; East CA; Larrabee WF
J Long Term Eff Med Implants; 1991; 1(1):53-77. PubMed ID: 10171107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
